ECMO before or after lung transplant to improve outcomes
Part of Lungs & breathing clinical trials.
This study looks at using a heart–lung machine (ECMO) to reduce complications and deaths after a lung transplant. It focuses on people getting a lung transplant who have certain types of lung-vessel (pulmonary) pressure problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Be evaluated for a bilateral sequential lung transplant for obstructive or restrictive lung disease
- Have French social security coverage
- Be able and willing to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This study looks at how well patients recover after needing a heart-lung bypass machine (VV-ECMO) during or right after emergency chest surgery. It aims to understand what affects their prognosis.
This study compares two ways of using a heart-lung machine (ECMO) during lung transplant surgery. The goal is to see if using ECMO only when needed works as well as using it for everyone. This could help reduce risks and improve recovery.
This study compares two ways of supporting the lungs and heart around the time of a double lung transplant: venoarterial ECMO versus an off-pump approach. It may help your team choose the safest support method based on your heart-lung pressures and surgical plan.
This study tests a special heart-lung support machine (ECMO) for people waiting for a lung transplant whose heart is failing due to high blood pressure in the lungs. The machine helps rest the heart and lungs until transplant surgery.
This trial compares two medical devices used to improve the condition of donor lungs before they are transplanted. It aims to see which device works better to make more lungs suitable for transplant, potentially helping more patients receive the lungs they need.
Hear when a new The Number of Ventilator-free Days in the 28 Days Following LT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.